SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    ) Maeda , H. , Takeshita , J. and Kanamaru , R. A lipophilic derivative of neocarzinostatin, A polymer conjugation to an antitumor protein antibiotic . Int. J. Peptide Protein Res. , 14 , 8187 ( 1979 ).
  • 2
    ) Maeda , H. , Matsumura , Y. , Oda , T. and Sasamoto , K. Cancer selective macromolecular therapeusis: tailoring of antitumor protein drugs . InProtein-tailoring for Food and Medical Uses ”, ed. R. E. Feeney and J. R. Whitaker , pp. 353381 ( 1986 ). Marcel Dekker , New York .
  • 3
    ) Matsumura , Y. and Maeda , H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS . Cancer Res. , 46 , 63876392 ( 1986 ).
  • 4
    ) Maeda , H. and Matsumura , Y. Tumoritropic and lymphotropic principle of macromolecular drugs . Crit. Rev. Ther. Drug Carrier Sys. , 6 , 193210 ( 1989 ).
  • 5
    ) Konno , T. , Maeda , H. , Iwai , K. , Tashiro , S. , Maki , S. , Morinaga , T. , Mochinaga , M. , Hiraoka , T. and Yokoyama , I. Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report . Eur. J. Cancer Clin. Oncol. , 19 , 10531065 ( 1984 ).
  • 6
    ) Konno , T. , Maeda , H. , Iwai , K. , Maki , S. , Tashiro , S. , Uchida , M. and Miyauchi , Y. Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium . Cancer , 54 , 23672372 ( 1984 ).
  • 7
    ) Iwai , K. , Maeda , H. and Konno , T. Use of oily contrast medium for selective drug targeting to tumor enhanced therapeutic effect and X-ray image . Cancer Res. , 44 , 21152121 ( 1984 ).
  • 8
    ) Iwai , K. , Maeda , H. , Konno , T. , Matsumura , Y. , Yamashita , R. , Yamasaki , K. , Hirayama , S. and Miyauchi , Y. Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver . Anticancer Res. , 7 , 321328 ( 1987 ).
  • 9
    ) Matsumura , Y. , Kimura , M. , Yamamoto , T. and Maeda , H. Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue . Jpn. J. Cancer Res. , 79 , 13271334 ( 1988 ).
  • 10
    ) Maeda , H. , Matsumura , Y. and Kato , H. Purification and identification of hydroxyprolyl3-bradykinin in ascitic fluid from a patient with gastric cancer . J. Biol. Chem. , 263 , 1605116054 ( 1988 ).
  • 11
    ) Margolius , J. The interrelationship of coagulation of plasma and release of peptides . Ann. N.Y. Acad. Sci. , 104 , 133145 ( 1963 ).
  • 12
    ) Jacobsen , S. Substrates for plasma kinin-forming enzymes in human, dog and rabbit plasmas . Br. J. Pharmacol. , 26 , 403411 ( 1966 ).
  • 13
    ) Lorand , L. HMW and LMW kininogens . Methods Enzymol. , 80 , 172198 ( 1981 ).
  • 14
    ) Erdös , E. G. Enzymes that inactivate active polypeptides . Biochem. Pharmacol. , 8 , 112118 ( 1961 ).
  • 15
    ) Sheikh , I. A. and Kapalan , A. P. Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum; role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products . Biochem. Pharmacol. , 38 , 9931000 ( 1989 ).
  • 16
    ) Matsumura , Y. , Maeda , H. and Kato , H. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC . Agents Actions , 29 , 172180 ( 1990 ).
  • 17
    ) Fujikawa , K. and Davie , E. W. Human factor XII (Hageman factor) . Methods Enzymol. , 80 , 198211 ( 1981 ).
  • 18
    ) Yamamoto , T. , Kozono , K. , Okamoto , T. , Kato , H. and Kambara , T. Purification of guinea-pig plasma prekailikrem: activation by prekallikrein activator derived from guinea-pig skin . Biochim. Biophys. Acta , 614 , 511525 ( 1980 ).
  • 19
    ) Quigley , J. P. , Ossowski , L. and Reich , E. Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses . J. Biol. Chem. , 249 , 43064311 ( 1974 ).
  • 20
    ) Oh-ishi , S. and Katori , M. Fluorometric assay for plasma prekallikrein using peptidyl-methylcoumarinylamide as a substrate . Thromb. Res. , 14 , 551559 ( 1979 ).
  • 21
    ) Molla , A. , Yamamoto , T. , Akaike , T. , Miyoshi , S. and Maeda , H. Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteinases . J. Biol. Chem. , 264 , 1058910594 ( 1989 ).
  • 22
    ) Ueno , A. , Oh-ishi , S. , Kitagawa , T. and Katori , M. Enzyme immunoassay of bradykinin using β-d-galactosidase as a labelling enzyme , Biochem. Pharmacol. , 30 , 16591664 ( 1981 ).
  • 23
    ) Kurooka , S. , Kaibe , K. , Ueyama , H , Kido , K. , Matsumura , Y. , Maeda , H. and Kato , H. The specific determination of hydroxyproly3-bradykinin using a competitive binding enzyme immunoassay . J. Immunol. Methods , 118 , 147149 ( 1989 ).
  • 24
    ) Maeda , H. , Ishida , N. , Kawauchi , H. and Tsuzimura , K. Reaction of fluoresceinisothiocyanate with proteins and amino acids. I. Covalent and non-covalent binding . J. Biochem. , 65 , 777783 ( 1969 ).
  • 25
    ) Pouneau-Schneider , N. , Delori , P. , Boutüre , B. , Arnoux , D. , George , F. , Sampol , J. and Martin , P. M. Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231 . J. Natl. Cancer Inst. , 81 , 259266 ( 1989 ).
  • 26
    ) Angeles-Cano , E. A spectrophotometric solid-phase fibrin-tissue plasminogen activator assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators . Anal. Biochem. , 153 , 201210 ( 1986 ).
  • 27
    ) Lowry , O. H. , Rosebrough , N. J. , Farr , A. L. and Randall , R. J. Protein measurement with the Folin phenol reagent . J. Biol. Chem. , 193 , 265275 ( 1951 ).
  • 28
    ) Peterson , H. I. and Appelgren , K. L. Experimental studies on the uptake and retention of labelled proteins in a rat . Eur. J. Cancer , 9 , 543547 ( 1972 ).
  • 29
    ) Dvorak , H. F. , Orenstein , N. S. , Carvalho , A. C. , Churchill , W. H. , Dvorak , A. M , Galli , S. J , Feder , J. , Bitzer , A. M. , Rypysc , J. and Giovinco , P. Induction of a fibrin gel investment: an early event in Line 10 hepatocarcinoma growth mediated by tumor-secreted products . J. Immunol. , 122 , 166174 ( 1979 ).
  • 30
    ) Senger , D. R. , Galli , S. J. , Dvorak , A. M. , Perruzi , C. A. , Harvey , V. S. and Dvorak , H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid . Science , 219 , 983985 ( 1983 ).
  • 31
    ) Fleck , A. , Raines , G. , Hawker , F. , Trotter , J. , Wallace , P. I. , Ledingham , I. M. and Caiman , K. C. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury . Lancet , i , 781784 ( 1985 ).
  • 32
    ) Dvorak , H. F. , Senger , D. R. , Dvorak , A. M. , Harvey , V. S. and McDonagh , J. Regulation of extravascular coagulation by microvascular permeability . Science , 227 , 10591061 ( 1985 ).
  • 33
    ) Greenbaum , L. M. , Grebom , P. , Johnston , M. , Prakash , A. and Semente , G. Pepstatin – an inhibitor of leukokinin formation and ascitic fluid accumulation . Cancer Res. , 35 , 706710 ( 1975 ).
  • 34
    ) Maeda , H. and Molla , A. Pathogenic potentials of bacterial proteases . Clin. Chim. Acta , 185 , 357368 ( 1989 ).
  • 35
    ) Matsumoto , K. , Yamamoto , T. , Kamata , R. and Maeda , H. Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease . J. Biochem. , 96 , 739749 ( 1984 ).
  • 36
    ) Mason , J. W , Kleeberg , U. , Dolan , P. and Colman , R. W. Plasma kallikrein activation and Hageman factor in Gram-negative bacteria . Ann. Intern. Med. , 73 , 545547 ( 1970 ).
  • 37
    ) Yamada , T. , Harber , P. , Pettit , G. W. , Wing , D. A. and Oster , C. N. Activation of the kallikrein-kinin system in Rocky Mountain spotted fever . Ann. Intern. Med. , 88 , 764768 ( 1978 ).
  • 38
    ) Markus , G. , Takita , H. , Camiolo , S. M. , Carsanti , J. G. , Everts , J. L. and Hobika , H. Content and characterization of plasminogen activators in human lung tissue . Cancer Res. , 40 , 841848 ( 1980 ).
  • 39
    ) Kirchheimen , J. C. , Roller , A. and Binder , B. R. Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue . Biochim. Biophys. Acta , 797 , 256265 ( 1984 ).
  • 40
    ) Tissot , J. D. , Hauert , J. and Bachmann , F. Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas . Int. J. Cancer , 34 , 295302 ( 1984 ).
  • 41
    ) Lang , W. , Jones , P. and Benedict , W. Relationship between fibrinolysis of cultured cells and malignancy . J. Natl. Cancer Inst , 54 , 173179 ( 1975 ).
  • 42
    ) Duffy , M. J. and O'Grudy , P. Plasminogen activator and cancer . Eur. J. Cancer Clin. Oncol. , 20 , 577582 ( 1984 ).
  • 43
    ) Folkman , J. and Cotran , R. Relation of vascular proliferation to growth . Int. Rev. Exp. Pathol. , 16 , 207248 ( 1976 ).
  • 44
    ) Folkman , J. and Handenschild , C. Angiogenesis in vitro . Nature , 288 , 551556 ( 1980 ).
  • 45
    ) Tarin , D. , Hoyt , B. J. and Evans , D. J. Correlation of collagenase secretion with metastatic colonization potential in naturally occurring marine mammary tumors . Br. J. Cancer , 46 , 266 ( 1982 ).
  • 46
    ) Damø , K. , Andreasen , P. A. , Grandahl-Hansen , J. , Kristensen , P. , Nielsen , L. S. and Slcriver , L. Plasminogen activators, tissue degradation, and cancer . Adv. Cancer Res. , 44 , 139266 ( 1985 ).
  • 47
    ) Colman , R. W. Surface-mediated defence reactions: the plasma contact activation system . J. Clin. Invest. , 73 , 12491253 ( 1984 ).
  • 48
    ) Kaplan , A. P. and Silverberg , M. The coagulation-kinin pathway of human plasma . Blood , 70 , 115 ( 1987 ).
  • 49
    ) Kozin , F. and Cochrane , C. G. The contact activation system of plasma: biochemistry and pathophysiology . InInflammation: Basic Principles and Clinical Correlates ”, ed. J. I. Gallin , I. M. Goldstein and R. Snyderman , pp. 101120 ( 1988 ), Raven Press , New York .
  • 50
    ) Fujikawa , K. , Heimark , P. L. , Kurachi , K. and Davie , E. W. Activation of bovine factor XII (Hageman factor) by plasma kallikrein . Biochemistry , 19 , 13221330 ( 1980 ).
  • 51
    ) Hasui , Y. , Suzumiya , J. , Marutsuka , K. , Sumiyoshi , A. , Hashida , S. and Ishikawa , E. Comparative study of plasminogen activators in cancers and normal mucosa of human urinary bladder . Cancer Res. , 49 , 10671070 ( 1989 ).
  • 52
    ) Takada , A. , Takada , Y. and Sugawara , Y. Effects of fibrinogen and fibrin on the activation of Glu- and Lysplasminogen by urokinase . Thromb. Res. , 33 , 561569 ( 1984 ).
  • 53
    ) Camiolo , S. M. , Thorsen , S. and Astrup , T. Fibrino-genolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin . Proc. Soc. Exp. Biol Med. , 138 , 277280 ( 1971 ).
  • 54
    ) O'Meara , R. A. Q. and Tackson , R. D. Cytological observations on carcinoma . Isr. J. Med. Sci. , 6 , 327328 ( 1958 ).
  • 55
    ) Hiramoto , R. , Bernecky , J. , Jurdndowski , J. and Pressman , D. Fibrin in human tumors . Cancer Res. , 20 , 592593 ( 1960 ).